高级检索

粪菌移植治疗腹泻型肠易激综合征患者的临床及护理实践

Clinical and nursing practice of fecal microbiota transplantation in treating diarrhea-predominant irritable bowel syndrome

  • 摘要: 目的:探讨经鼻肠管滴注行粪菌移植治疗腹泻型肠易激综合征(irritable bowel syndrome, IBS)患者的护理措施,观察粪菌移植后患者的腹泻症状及舒适度的改善情况。方法:回顾分析2016年4月至10月复旦大学附属中山医院消化科收治的腹泻型肠易激综合征并行粪菌移植治疗的7例患者的相关资料。总结采用的一系列护理措施,记录患者住院期间的不良反应,比较粪菌移植前后患者的日排便次数、Bristol粪便性状评分(Bristol stool form scale, BSFS)与Kolcaba简化舒适状况量表(general comfort questionnaire,GCQ)评分。结果:通过一系列临床治疗及护理干预,患者粪菌移植后日排便次数和BSFS均显著降低(P<0.01),GCQ评分显著升高(P=0.004)。粪菌移植后部分患者出现恶心、呕吐、发热、腹泻加重等不良反应。结论:粪菌移植可使患者的腹泻症状好转、舒适度提高,规范化的护理措施值得临床推广。

     

    Abstract: Objective:To investigate the nursing care of diarrhea predominant irritable bowel syndrome (IBS-D) patients treated with fecal microbiota transplantation (FMT) and the improvement of diarrhea symptoms and comfort degree of patients after FMT. Methods:A retrospective analysis was conducted in IBS-D patients receiving nasointestinal FMT from April to October, 2016. We summarized the nursing interventions, recorded the adverse reactions after FMT, and used Bristol stool scale and general comfort questionnaire (GCQ) to estimate the changes of patients’ parameters. Results:Through the clinical treatment and a series of nursing interventions, the frequency of defecation and scores of Bristol fecal property decreased significantly (P<0.01), while the scores of GCQ had a significant improvement (P=0.004). However, some adverse reactions were observed, such as nausea, vomiting, fever, and an aggravation of diarrhea. Conclusions:FMT can improve patients’ diarrhea symptoms and improve their comfort, standardized nursing measures are worthy of clinical promotion.

     

/

返回文章
返回